245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA
Financial Results, Press Release
Other Events
Reports Third Quarter 2025 Financial Results and Provides Business and Clinical Updates
News, Underwriting Agreement, Legal Opinion
Immuneering Announces Public Offering and Private Placement to Sanofi
Announces $25 Million Private Placement
Reports Second Quarter 2025 Financial Results and Provides Business Updates
FY 2025
Q3
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Notice of Exempt Offering of Securities
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Free Writing Prospectus
Correspondence
Submission Upload